Close this search box.

Bev's Story

Participant Story

Bev Snedden

Hunter Valley, NSW


When Bev Snedden was diagnosed with non-Hodgkin lymphoma in 2011, her positive outlook on life was put to the test. But the chance to join the TROG 99.03 clinical trial gave Bev the opportunity to be part of the “bigger picture”
“I was first diagnosed with a lymphoma in 2011 after unsuccessful attempts to get to the bottom of a swollen cheek,” Bev said.

“At that stage, I was totally unaware of what and how dangerous a lymphoma was and the impact it would make on my quality of life. I found this news to be confronting and challenging. I have always had a positive attitude to life, so I just got on with it and reported to the hospital as requested to see what the next steps would be.

“I was then offered a place on a clinical trial which, not only treated the lymphoma with the standard treatment of radiation but also added immuno-chemotherapy treatment Cyclophosphamide, Vincristine, Prednisolone (CVP) and Rituximab.

“I wrote off the whole year of 2012 as the treatment took place. In hindsight, the process was smooth sailing. The complexity of what was happening to me was overwhelming and I admit that there were times when I had doubts about getting through, but this was the chance to live a full and healthy life.

“Together with a team of friendly, supportive and caring staff I now have the all-clear from this horrible cancer and know that this trial has not only helped me but will help others overcome the same challenges.

“With regular follow-ups, I have the assurance that “the team” is looking over my shoulder – and that gives me the confidence to live my life to it’s fullest. I now have a new perspective; to enjoy life and to do all the things that are important to me and as I see it – that can be only a good thing.”

Our Charity Status

TROG Cancer Research is a registered charity in Australia, holding the Deductible Gift Recipient (DGR) status, which means that donations over $2 are tax-deductible.